Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 2,196 shares at $132.99 ($292K) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Scheduled sale ($292k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $132.99 | 1,098 | $146K | 50.0% |
| 2 | $132.99 | 1,098 | $146K | 50.0% |
| Total | $132.99 avg | 2,196 | $292K | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |